Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot study of once-daily raltegravir pharmacokinetics in HIV-1 infected adults
2009-014313-27Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Sep 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of raltegravir in Human immunodeficiency virus infection type 1, sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoints: Plasma raltegravir concentration, Intracellular raltegravir concentration and 1 more. Started Sep 2009; status: completed.
02
Drugs
raltegravir
03
Conditions
Human immunodeficiency virus infection type 1
Beyond the preview
Go deeper on 2009-014313-27.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014313-27.